Introduction
The relationship between epilepsy and psychological disturbance has prompted numerous studies in recent years. Studies have generally found a higher prevalence of affective disorders, especially depression, in patients with epilepsy than among healthy controls or people with other medical disorders. Epilepsy patients with comorbid depression have significantly more visits to doctors, emergency departments, and hospitals than patients with epilepsy. The Epilepsy Impact Survey has demonstrated that health resource utilization in patients with epilepsy differs only by depression status, not by seizure type or frequency, even in those who have only few or minor seizures. 1 Furthermore, depression affects reported seizure severity. People with moderate to severe depression report significantly worse problems than those with no depression with respect to severity of seizures as well as cognitive, emotional, and physical aspects of seizure recovery. 2 Depression in epilepsy patients can be classified according to the onset of psychiatric symptoms and seizure occurrence into ictal (the depressive symptoms are a clinical manifestation of the seizure), periictal (symptoms precede and/or follow the seizure occurrence), and interictal (symptoms occur independently of the seizure occurrence). 3 Interictal depression is the most frequently recognized type of depression in patients with epilepsy.
In this study, we aimed to determine the frequency of interictal depression among patients with epilepsy who attend our tertiary epilepsy center clinic and analyze possible risk factors for depression in patients with epilepsy.
Method
All patients analyzed in this study were outpatients attending the epilepsy center in Huashan Hospital at Fudan University from August 2007 to February 2008. All subjects had a confirmed diagnosis of epilepsy based on documented clinical data and EEG monitoring, and were taking anti-epilepsy drugs (AEDs). The classification of epilepsy was defined according to the ILAE classifications published in 1989. 4 Patients with cognitive impairment who could not complete the questionnaires and those with severe organic brain diseases were excluded from this study. No patients were being treated with drugs that influence the central nervous system, except for antiepileptic and anti-depressive drugs. All patients signed an informed consent document as required by the institutional ethics committee. In the interictal period, at least 24 h after the last epileptic seizure, all patients underwent the same research protocol. Data were collected including patient age, gender, disease history, physical and neurological examination results, age of onset, duration of epilepsy, number of self-reported seizures in the previous 6 months, and use of AEDs. The Hamilton Depression Rating Scale (HAMD) 5 and Quality of Life in Epilepsy-31 (QOLIE-31) 6 were administered. Against Epilepsy classification of epileptic seizures 7 and was supported by the EEG findings. Depression was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria and assessed by the HAMD-17. The HAMD-17 includes 17 questions regarding depressed mood, feelings of guilt, suicide, insomnia early (difficulty going to sleep), insomnia middle (waking during the night), insomnia late (waking in early morning hours), work and activities, psychomotor retardation, agitation, anxiety (psychological), anxiety (somatic), somatic symptoms (gastrointestinal), somatic symptoms (general), sexual interest, hypochondriasis, loss of weight, and insight. The scale scores range from 0 to 54, with higher scores representing more severe depression. Scores of 0-6 are considered normal, with scores of 7-17 considered a mild, 18-24 a moderate, 19-22 a severe, and !24 a very severe level of depression. Dimensions of quality of life in epilepsy were assessed using the QOLIE-31, a self-report instrument that assesses the major domains of health-related quality of life (HRQOL). This instrument includes 31 questions divided into seven domains: seizure worry, effects of epilepsy medications, emotional wellbeing, energy/fatigue, cognitive function, social function, and overall quality of life. Some scores are converted during the scoring process so that higher scores always reflect better quality of life. The Chinese version of HAMD-17 and QOLIE-31 scales both have tested for validity and reliability before and proved to be satisfactory for accession in Chinese context. 8, 9 The data analysis was performed with SPSS 11.5. Pearson's chi square test and a one-way ANOVA were used to evaluate differences in categorical and quantitative data on epilepsy patients with and without depression. Variables identified as probably related to depression were included in a logistic regression model. Summary statistics were reported as means AE SDs, and the statistical significance level was set at P < 0.05.
Results
One hundred and forty patients (50% males) with a confirmed diagnosis of epilepsy were included in this study. Ages ranged from 15 to 71 years. Demographic characteristics of these patients are listed in Table 1 .
With respect to all patients, nearly half the cases were classified as primary epilepsy (46.4%) and about half as secondary epilepsy (53.6%). Of the 140 patients, 99 (70.7%) had simple or complex partial seizures, 91 (65.0%) had generalized seizures, and 50 (35.7%) suffered from two or more types. Forty-six (32.9%) patients received AED polytherapy; 94 (67.1%) received monotherapy.
Thirty-six (25.7%) patients with epilepsy had comorbid depression, including 22 (61.1%) males and 14 (38.9%) females. One female and one male (5.6%) had severe depression (HAMD-17 score >24). Among these patients, the duration of epilepsy was 2 months to 44 years, and the age of seizure onset ranged from 1 to 67 years. More than half the cases (21; 58.3%) were classified as primary epilepsy. Seventeen (47.2%) patients presented with only one seizure type, while 19 (52.8%) suffered from two or more types. Fifteen (41.7%) patients received more than one AED. The most commonly used drug was carbamazepine (20 patients; 55.6%), followed by valproic acid (12; 33.3%), topiramate (8; 22.2%), clonazepam (5; 13.9%), phenytion (4; 11.1%), and lamotrigine (3; 8.3%).
The analysis of epilepsy patients with and without depression, and the results of Pearson's chi-square test and one-way ANOVA between the two groups are shown in Table 2 . There were no significant differences in gender, mean duration of epilepsy, mean age of seizure onset, etiology, or number of concomitant AEDs. Some clinical variables and QOILE-31 scores showing differences in patients with and without depression were analyzed in a logistic regression model, including number of seizure types, seizure frequency, complex partial seizures, overall QOILE-31 scores, seizure worry scores, and social function scores. The results are presented in Fig. 1 . The strongest predictor of depression was number of seizure types (odds ratio (OR) = 3.773, P = 0.049, B = 1.328). Seizure worry scores (OR = 0.947, P = 0.030, B = À0.54), social function scores (OR = 0.947, P = 0.000, B = À0.10), and complex partial seizure scores (OR = 0.112, P = 0.002, B = À2.187) yielded a weaker predictive value. Other factors showed a relationship to depression in univariate analysis, but were excluded from logistic regression analysis.
Discussion
Patients with epilepsy have a higher lifetime prevalence of depression than individuals without epilepsy. 10 The prevalence of depression in epilepsy ranges from 20% to 55% in patients with recurrent seizures and from 3% to 9% in patients with controlled epilepsy. 3 In our patient population, 25.7% had depression, which is similar to findings in other studies. 3, 11 We also found that the frequency of severe depression requiring treatment was similar to that reported in previous studies. 12, 13 Gender, duration of epilepsy, age of onset, and etiology of epilepsy had no association with depression. Many previous studies have found that more seizure types, more seizure frequency, and more AED usage are associated with a higher prevalence rate of depression in patients with epilepsy. 14, 15 In this study, we obtained similar data. The number of seizure types was a positive predictor for depression, and seizure frequency was significantly different between those with and without depression according to Pearson's chi-square test. It is possible that more seizure types and more seizure frequency reflect a more severe course of epilepsy and more difficult-to-treat seizures. However, amount of AEDs only represented a trend, with an insignificant difference between the patients with and without depression. This may be attributable to the limited amount of data. If more patients were brought into this study, a significant difference might be found.
Our study confirmed that complex partial seizures are a positive risk factor for depression in patients with epilepsy. This type of seizure is usually recurrent and has been associated with depression. 16 Furthermore, most complex partial seizures are originated from the temporal and frontal lobes, which have been identified as positive predictors for depression in patients with epilepsy. 17, 18 In both depression and epilepsy, atrophy of the mesial temporal structures and changes in the amygdala (in temporal epilepsy), prefrontal cortex, cingulate gyrus, and white matter (in frontal epilepsy) have been reported. 19 This shared underlying pathology may predispose patients to both complex partial seizures and depression. There is a decrease in 5-HT 1A receptor binding in patients with depression, 20 and similar abnormalities in 5-HT 1A receptor binding have been identified in patients with temporal lobe epilepsy. 21, 22 Furthermore, patients with temporal lobe epilepsy and depression exhibit a significantly more pronounced reduction in 5-HT 1A receptor binding than patients with either single disease. 23 Patients with epilepsy and comorbid depression have significant neuropsychological, psychiatric, and social impairments that limit their education, employment opportunities, and possibilities for marriage. Furthermore, depression is recognized as a predictor of poor QOL in patients with epilepsy. 2, 24, 25 Our study showed that the subscales of seizure worry and social function on the QOLIE-31 were independent negative predictors of depression in patients with epilepsy. Thus, not only does depression negatively affect QOL in patients with epilepsy, but low QOL scores, especially related to aspects of seizure worry and social function, increase the possibility of comorbid depression. This finding indicates a bidirectional relationship between depression and QOL in these patients. Thus, we should attend more to QOL in patients with epilepsy, not only in regard to seizures, but also to reduce the incidence of comorbid depression. Seizure severity (based on a medical evaluation) may not coincide with seizure worry (subjective evaluation of seizure situations). Self-evaluation of what it means to be sick, to have seizures, and to control one's seizures are parameters of personal QOL. 26 Souza concluded that the perception patients have about their condition affects their mood more than the condition itself. 27 This suggests that the more worried patients are about seizures, the more depressed they may be, even if the seizure severity does not change. The presence of mood disorders has an influence on the choice of AEDs. Carbamazepine, valproic acid, and lamotrigine have mood stabilizing properties. Carbamazepine and valproic acid have antimanic effects, and lamotrigine has antidepressant effects in patients with bipolar disorder. In our study, there was not a significant difference in depression in patients on these AEDs compared with those not taking them, consistent with other studies. 15 Data demonstrating the efficacy of these medications in the management of depression are limited and more supportive of their use as adjuncts to other psychotropic medications than as monotherapy. 28 A major limitation of our study is that our institution was a tertiary epilepsy center. Our patients probably had more seizure frequency, took more AEDs, were more difficult to treat and accordingly, had a higher rate of depression. Studies with a community-based design should be conducted to determine a relatively realistic depression rate in patients with epilepsy. The findings in this study suggest that at tertiary epilepsy centers such as ours in China, the prevalence rate of depression is as high as in other countries. 3, 11 Therefore, it is very important for doctors to be aware of this life-threatening comorbid symptom, routinely evaluate depression in patients with epilepsy, and diagnose and treat comorbid depression when needed.
